| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 173 |
| 1 | METFORMIN | 97 |
| 2 | METFORMIN ER 500 MG | 97 |
| 3 | METFORMIN ER 750 MG | 97 |
| 4 | PREGABALIN | 94 |
| 5 | PREDNISONE | 93 |
| 6 | ADALIMUMAB | 91 |
| 7 | SPIRONOLACTONE | 90 |
| 8 | RITUXIMAB | 87 |
| 9 | METHOTREXATE SODIUM | 85 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ONTRUZANT | 8 | 0.0153 |
| 1 | CROVALIMAB | 1 | 0.0083 |
| 2 | ALMOTRIPTAN | 7 | 0.0066 |
| 3 | RIVASTIGMINE TARTRATE | 3 | 0.0065 |
| 4 | GOLD | 37 | 0.0064 |
| 5 | SEROTONIN | 1 | 0.0037 |
| 6 | CETRORELIX ACETATE | 2 | 0.0032 |
| 7 | INSULIN DEGLUDEC AND LIRAGLUTIDE | 5 | 0.0030 |
| 8 | MEXILETINE HYDROCHLORIDE | 1 | 0.0024 |
| 9 | DIFLUPREDNATE OPHTHALMIC | 2 | 0.0023 |
| # | Drug class | Count |
|---|---|---|
| 0 | Loop Diuretic [EPC] | 192 |
| 1 | Corticosteroid [EPC] | 175 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 135 |
| 3 | Dihydropyridine Calcium Channel Blocker [EPC] | 97 |
| 4 | Aldosterone Antagonist [EPC] | 94 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 91 |
| 6 | Angiotensin 2 Receptor Blocker [EPC] | 89 |
| 7 | Proton Pump Inhibitor [EPC] | 89 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 88 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 85 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Complement C5 Inhibitor [EPC] | 1 | 0.0083 |
| 1 | Vasopressin V2 Receptor Antagonist [EPC] | 21 | 0.0014 |
| 2 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 41 | 0.0009 |
| 4 | Phosphodiesterase 3 Inhibitor [EPC] | 5 | 0.0008 |
| 5 | Osmotic Diuretic [EPC] | 4 | 0.0008 |
| 6 | Nucleoside Analog Antifungal [EPC] | 1 | 0.0007 |
| 7 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 8 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 75 | 0.0007 |
| 9 | Antirheumatic Agent [EPC] | 71 | 0.0007 |